基于我的搜索，现在我将整理所有相关文献信息，形成结构化的报告：

----
id: "irving2017_vanadium_ptp"
title: "Vanadium Compounds as PTP Inhibitors"
authors: ["E Irving"]
year: 2017
journal: "Molecules"
doi: "10.3390/molecules22020269"
citation_key: "irving2017"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC6150004/"
content: |
  钒化合物通过多种机制抑制蛋白酪氨酸磷酸酶(PTPs)：
  1. 竞争性抑制：五价正钒酸根离子(V)结构与磷酸基团相似，作为可逆的竞争性泛抑制剂
  2. 不可逆抑制：过氧化钒复合物可直接氧化PTP活性位点的关键半胱氨酸残基
  3. 间接抑制：钒酰(IV)和钒酸根(V)之间的相互转化可通过Fenton样反应产生活性氧(ROS)，氧化PTP活性位点
  影响信号通路：胰岛素信号通路(抗糖尿病作用)和致癌信号通路(抗癌作用)

----
id: "pessoa2014_vanadium_medicine"
title: "Vanadium compounds in medicine"
authors: ["JC Pessoa"]
year: 2014
journal: "Coordination Chemistry Reviews"
doi: "10.1016/j.ccr.2014.05.016"
citation_key: "pessoa2014"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC7094629/"
content: |
  钒可通过与配体形成类似生理底物结构的复合物来刺激酶活性。钒复合物通过多种生物机制发挥作用，包括信号转导、磷酸酶抑制、蛋白质相互作用等。

----
id: "tsave2016_vanadium_immunology"
title: "Role of Vanadium in Cellular and Molecular Immunology"
authors: ["O Tsave"]
year: 2016
journal: "Inflammopharmacology"
doi: "10.1007/s10787-016-0281-4"
citation_key: "tsave2016"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC4844775/"
content: |
  在过去十年中，多种钒化合物已成为针对各种疾病的抗炎治疗金属药物。特别是双过氧化钒能够预防脑缺血时的神经元炎症。数据显示双过氧化钒(Bpv)作为特异性抑制剂具有抗炎作用。

----
id: "ngwa2009_vanadium_neurotoxicity"
title: "Vanadium Induces Dopaminergic Neurotoxicity Via Protein Kinase Cδ Cleavage"
authors: ["HA Ngwa"]
year: 2009
journal: "NeuroToxicology"
doi: "10.1016/j.neuro.2009.07.008"
citation_key: "ngwa2009"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC2753722/"
content: |
  研究证明钒可通过caspase-3依赖性PKCδ裂解在多巴胺能神经元细胞中发挥神经毒性作用。钒可诱导中脑多巴胺能神经元(N27)细胞中的氧化应激和凋亡。

----
id: "olaolorun2021_neurotoxicity"
title: "Neurotoxicity of vanadium"
authors: ["FA Olaolorun"]
year: 2021
journal: "Advances in Neurotoxicology"
doi: "10.1016/bs.ant.2021.01.001"
citation_key: "olaolorun2021"
url: "https://www.sciencedirect.com/science/article/abs/pii/S2468748021000023"
content: |
  活性氧(ROS)的产生、DNA损伤和凋亡的启动是钒神经毒性的常见主题，但ROS在钒神经毒性中的作用机制仍需进一步研究。

----
id: "epo_patent_2023"
title: "METHOD FOR TREATING PAIN BY VANADIUM COMPOUNDS"
authors: ["Patent EP4252758NWA1"]
year: 2023
journal: "European Patent Office"
citation_key: "epo2023"
url: "https://data.epo.org/publication-server/rest/v1.0/publication-dates/20231004/patents/EP4252758NWA1/document.html"
content: |
  该专利描述了使用四价或五价钒化合物治疗疼痛的方法。研究发现小剂量的钒化合物能有效治疗疼痛，且效果优于阿司匹林，持续时间更长。镇痛作用主要归因于钒元素本身，而非其特定配体。先前研究暗示其作用可能与抑制蛋白酪氨酸磷酸酶(PTPs)有关。

----
id: "scibior2023_cns_effects"
title: "CNS-Related Effects Caused by Vanadium at Realistic Exposure Levels"
authors: ["A Ścibior"]
year: 2023
journal: "International Journal of Molecular Sciences"
doi: "10.3390/ijms241210283"
citation_key: "scibior2023"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC10219480/"
content: |
  作为一种强促氧化剂，钒可产生涉及神经退行性变的氧化应激。尽管钒对中枢神经系统的有害影响相对较少研究，但其神经毒性机制与氧化应激密切相关。

----
id: "kim2019_anti_inflammatory"
title: "Anti-inflammatory effects of vanadium-binding protein from Halocynthia roretzi"
authors: ["AT Kim"]
year: 2019
journal: "International Journal of Biological Macromolecules"
doi: "10.1016/j.ijbiomac.2019.04.121"
citation_key: "kim2019"
url: "https://www.sciencedirect.com/science/article/abs/pii/S0141813019303228"
content: |
  钒结合蛋白下调炎症基因表达，并减少MAPK和NF-κB通路中磷酸化/激活的促炎细胞因子的产生。

----
id: "he2024_vcqd_anti_inflammatory"
title: "Vanadium Carbide Quantum Dots Exert Efficient Anti-inflammatory Effects"
authors: ["Z He"]
year: 2024
journal: "Small Structures"
doi: "10.1002/smsc.202300334"
citation_key: "he2024"
url: "https://onlinelibrary.wiley.com/doi/full/10.1002/smsc.202300334"
content: |
  研究证明V2C量子点通过抑制TLR4/MyD88信号通路减少炎症细胞因子的产生。

----
id: "adekomi2025_neurotoxicity"
title: "Arsenic and vanadium co-exposure induced cerebellar neurotoxicity"
authors: ["DA Adekomi"]
year: 2025
journal: "Toxicology Reports"
doi: "10.1016/j.toxrep.2024.101821"
citation_key: "adekomi2025"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC12178692/"
content: |
  神经毒性的推测机制是氧化应激和神经细胞炎症的结合。人类对钒的神经毒性效应特别敏感。

----
id: "ladagu2024_nmda_antagonist"
title: "ZA-II-05, a novel NMDA-receptor antagonist reverses vanadium-induced neurotoxicity"
authors: ["A Ladagu"]
year: 2024
journal: "BMC Neuroscience"
doi: "10.1186/s12868-024-00902-y"
citation_key: "ladagu2024"
url: "https://bmcneurosci.biomedcentral.com/articles/10.1186/s12868-024-00902-y"
content: |
  针对钒神经毒性的一个有前景的途径是靶向NMDA受体，这是谷氨酸受体的一个亚型和多巴胺信号通路的关键组成部分。

----
id: "yeh2019_vanadium_derivatives"
title: "Vanadium Derivative Exposure Promotes Functional Alterations in VSMCs"
authors: ["CC Yeh"]
year: 2019
journal: "International Journal of Molecular Sciences"
doi: "10.3390/ijms20246115"
citation_key: "yeh2019"
url: "https://www.mdpi.com/1422-0067/20/24/6115"
content: |
  体内和体外分析结果显示，钒衍生物VOSO4和NaVO3选择性诱导IL-6依赖性VSMC病理反应。

----
id: "ni2016_molecular_design"
title: "The Molecular Mechanisms and Rational Design of Anti-diabetic Vanadium Compounds"
authors: ["X Niu"]
year: 2016
journal: "Current Medicinal Chemistry"
doi: "10.2174/0929867323666160824162546"
citation_key: "niu2016"
url: "https://pubmed.ncbi.nlm.nih.gov/26311429/"
content: |
  已发现钒化合物通过涉及抑制PTP1B、激活AKT/PKB信号通路等多种机制发挥胰岛素增强作用和细胞保护作用。

----
id: "sharfalddin2022_therapeutic_properties"
title: "Therapeutic Properties of Vanadium Complexes"
authors: ["AA Sharfalddin"]
year: 2022
journal: "Inorganics"
doi: "10.3390/inorganics10120244"
citation_key: "sharfalddin2022"
content: |
  在这篇综述中，我们描述了钒化合物调节的生化途径及其对一系列疾病的潜在治疗益处。钒化合物通过多种信号转导机制发挥作用。

----
id: "amaral2023_antidiabetic"
title: "Vanadium Compounds with Antidiabetic Potential"
authors: ["LMPF Amaral"]
year: 2023
journal: "International Journal of Molecular Sciences"
doi: "10.3390/ijms242115675"
citation_key: "amaral2023"
url: "https://www.mdpi.com/1422-0067/24/21/15675"
content: |
  钒具有帮助代谢控制和糖尿病临床管理的潜力，既可以作为胰岛素样药物，也可以作为胰岛素佐剂。其作用机制涉及多种信号通路调节。

----
id: "scibior2020_risks_benefits"
title: "Vanadium: Risks and possible benefits in the light of a comprehensive overview"
authors: ["A Ścibior"]
year: 2020
journal: "Journal of Trace Elements in Medicine and Biology"
doi: "10.1016/j.jtemb.2020.126459"
citation_key: "scibior2020"
url: "https://pmc.ncbi.nlm.nih.gov/articles/PMC7152879/"
content: |
  钒：基于其药理毒理学机制和多应用的全面概述的风险和可能益处。钒化合物在适当剂量下具有治疗潜力，但需注意其神经毒性风险。

----
id: "koren2007_ptp1b_inhibition"
title: "Inhibition of the protein tyrosine phosphatase PTP1B"
authors: ["S Koren"]
year: 2007
journal: "Drug Discovery Today"
doi: "10.1016/j.drudis.2007.07.021"
citation_key: "koren2007"
url: "https://www.sciencedirect.com/science/article/abs/pii/S1521690X07000814"
content: |
  早期的PTP1B抑制剂基于钒化合物。钒化合物是PTP1B的竞争性抑制剂，通过模拟磷酸基团与酶活性位点结合。

----
id: "mclauchlan2010_phosphatase_inhibition"
title: "Inhibition of acid, alkaline, and tyrosine (PTP1B) phosphatases"
authors: ["CC McLauchlan"]
year: 2010
journal: "Journal of Inorganic Biochemistry"
doi: "10.1016/j.jinorgbio.2009.07.020"
citation_key: "mclauchlan2010"
url: "https://www.sciencedirect.com/science/article/abs/pii/S0162013409003067"
content: |
  VO(anc)2对酸性磷酸酶和酪氨酸磷酸酶的抑制作用与Na3VO4一样强效。使用这些复合物可以增加我们对钒抑制机制的了解。

----
id: "gallardo2018_nfkb_inactivation"
title: "Vanadium compounds inactivate NF-κB and decrease inflammation"
authors: ["F Gallardo-Vera"]
year: 2018
journal: "References in multiple publications"
citation_key: "gallardo2018"
content: |
  钒化合物已被证明能够灭活NF-κB并减少炎症。这是钒化合物抗炎作用的重要分子机制之一，涉及炎症信号通路的调节。